The CD271 expression could be alone for establisher phenotypic marker in Bone Marrow derived mesenchymal stem cells.

Authors:
  • OGOscar R Gonzalez-Ramella
    Oscar R Gonzalez-Ramella
  • ACAntonio Carrasco-Yalan
    Antonio Carrasco-Yalan
  • KGKarlen Gazarian
    Karlen Gazarian
  • SCSilvio Cuneo-Pareto
    Silvio Cuneo-Pareto

Abstract
Mesenchymal stem cells (MSCs) are of great interest for their potential use in cellular therapies. To define the population more precisely, diverse surface markers have been used. We propose here to use CD271 as the sole marker for MSCs in fresh bone marrow. We compared CD271+ populations to the presence or absence of five defined markers for MSCs: CD90+, CD105+, CD45-, CD34- and CD79. The correlations between markers were evaluated and analyzed with a Pearson's correlation test. We found that the average percentage of cells expressing the combination of markers CD90+, CD105+, CD45-, CD34- and CD79- was 0.54%, and that the average percentage average of CD271+ cells was 0.53%. The results were significant (p

This publication has 26 references indexed in Scilit: